Skip to content

Startups

Koronis Pharmaceuticals

Startup thumbnail placeholder image

Sectors
Health & Medicine

Launched
01/01/1999

Description

Koronis Pharmaceuticals (formerly VDA Pharma) has developed antiviral therapeutics based on Viral Decay Acceleration (VDA) – a novel drug mechanism.

Team Members

Lawrence Loeb

Scientific Advisor and Director of Medical Science Training Program at University of Washington

James Mullins

Scientific Advisor and Professor of Microbiology at University of Washington

John Essigman

Scientific Advisor and Professor of Toxicology and Chemistry at MIT